Lower risk of dementia with pioglitazone, compared with other second-line treatments, in metformin-based dual therapy: a population-based longitudinal study
Lu C-H, Yang C-Y, Li C-Y, et al.
Diabetologia. 2018;61:562-73
Leggi
Lu C-H, Yang C-Y, Li C-Y, et al.
Diabetologia. 2018;61:562-73
Leggi
Murphy HR, Bell R, Dornhorst A, et al.
Diabetic Medicine. Pub. online 13 February 2018
Leggi
Steinarsson AO, Rawshani A, Gudbjörnsdottir S, et al.
Diabetologia. 2018;61:599-606
Leggi
Jeevarethinam A, Venuraju S, Dumo A, et al.
American Journal of Cardiology. Pub. Online February 3, 2018.
Leggi
Sartorius K, Sartorius B, Madiba TE, et al.
BMJ Open 2018;8:e018449
Leggi
Goldacre RR
Diabetologia. 2018;61:616-25
Leggi
Xu F, He J, Wang Z, et al.
Diabetic Med. Pub. online February 8, 2018
Leggi
Biesty LM, Egan AM, Dunne F, et al.
The Cochrane Library. Pub. online 9 February 2018
Leggi
Tu H, Wen CP, Tsai SP, et al.
BMJ 2018;360:k134
Leggi
Patorno E, Goldfine AB, Schneeweiss S, et al.
BMJ 2018;360:k119
Leggi